Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-14 Sale |
2020-12-16 3:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
5,250 | $30 | $157,500 | 168,145 (Indirect Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 7:40 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $25.98 | $57,155 | 249,464 (Indirect Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 4:33 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $18.27 | $40,186 | 250,442 (Indirect Direct) |
View |
| 2020-10-02 Purchase |
2020-10-06 5:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
| 2020-10-02 Purchase |
2020-10-06 5:23 pm |
Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
| 2020-10-01 Sale |
2020-10-05 9:13 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $27.65 | $60,829 | 251,420 (Indirect Direct) |
View |
| 2020-09-01 Sale(A) |
2020-10-05 9:12 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $24.38 | $53,643 | 252,398 (Indirect Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 9:02 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $30 | $90,000 | 933,057 (Indirect Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 9:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
15,000 | $30 | $450,000 | 389,235 (Indirect Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 9:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $30 | $52,500 | 172,072 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 11:48 am |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $24.38 | $53,643 | 214,979 (Indirect Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 5:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $25.63 | $71,764 | 238,412 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $0 | 168,145 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $1.6806 | 168,145 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 232,549 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 232,549 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 7:40 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 249,464 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 7:40 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 249,464 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 11:57 am |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 11:57 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
| 2020-11-02 Option Award |
2020-11-04 4:34 pm |
N/A 2030-11-02 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 4:33 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 250,442 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 4:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 250,442 (Direct) |
View |
| 2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $0 | 168,943 (Direct) |
View |
| 2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $0 | 168,943 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $0 | 168,943 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 9:13 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 251,420 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 9:13 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 251,420 (Direct) |
View |
| 2020-09-01 Exercise(A) |
2020-10-05 9:12 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 252,398 (Direct) |
View |
| 2020-09-01 Exercise(A) |
2020-10-05 9:12 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 252,398 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:02 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $0 | 933,057 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:02 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $1.6806 | 933,057 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 172,072 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 172,072 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 5:57 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 5:57 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-02 11:48 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 214,979 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-02 11:48 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 214,979 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-21 2:19 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $0 | 246,151 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-21 2:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $1.68 | 246,151 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-19 5:48 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,076 | $0 | 209,836 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-19 5:48 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,076 | $1.68 | 209,836 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-18 4:12 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,110 | $0 | 221,643 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-18 4:12 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,110 | $0.5802 | 221,643 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:11 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $0 | 238,412 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:11 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $1.68 | 238,412 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 5:02 pm |
N/A 2030-08-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
353,500 | $0 | 353,500 (Direct) |
View |